Drug-induced gingival overgrowth: old problem, new problem.
about
A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1Oral pathology in inflammatory bowel diseaseLevels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporine AMechanism of drug-induced gingival overgrowth revisited: a unifying hypothesisGenetic heterogeneity of gingival fibromatosis on chromosome 2p.Increased expression of vascular endothelial growth factor in cyclosporin A-induced gingival overgrowth in rats.The impact of molecular genetics on oral health paradigms.Dental plaque-induced gingival diseases.Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus.Surgical treatment of gingival overgrowth with 10 years of follow-up.Speech intelligibility after gingivectomy of excess palatal tissue.Treatment of plaque-induced gingivitis, chronic periodontitis, and other clinical conditions.Genetic linkage of hereditary gingival fibromatosis to chromosome 2p21.Molecular and clinical aspects of drug-induced gingival overgrowth.Sodium valproate induced gingival enlargement in 22 months old child.Treatment of periodontal disease in the immunodeficient patient.Prevention of phenytoin-induced gingival overgrowth by lovastatin in miceDefining periodontal healthConnective tissue metabolism and gingival overgrowth.Oral and dental aspects of chronic renal failure.Gingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review.Combined treatment approach to gingival overgrowth due to drug therapy.Propranolol-induced gingival hyperplasia with Nager syndrome: A rare adverse drug reaction.Requirement for active glycogen synthase kinase-3β in TGF-β1 upregulation of connective tissue growth factor (CCN2/CTGF) levels in human gingival fibroblasts.Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features.The possible potential therapeutic targets for drug induced gingival overgrowth.Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCNImmunoexpression of interleukin-6 in drug-induced gingival overgrowth patients.Oral health of pediatric liver transplant recipients.Matrix metalloproteinases (MMP-8 and -9) and neutrophil elastase in gingival crevicular fluid of cyclosporin-treated patients.Multidrug resistance 1 gene polymorphism in amlodipine-induced gingival enlargement.Medications as risk factors for periodontal disease.Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues?Periodontal probing.Characterization of fibroblast clones from periodontal granulation tissue in vitro.Effects of aging and cyclosporin a on collagen turnover in human gingiva.Phenytoin increases gene expression for platelet-derived growth factor B chain in macrophages and monocytes.Phenytoin-induced severe gingival overgrowth in a child.Effect of cyclosporin A on proliferation and differentiation of human periodontal ligament cells.The role of inflammation and apoptosis in cyclosporine A-induced gingival overgrowth.
P2860
Q24613504-FD4B02E6-26EC-4E60-800F-E71B9DBE9378Q26739055-215D86FB-5020-4B53-85CC-BE0DFE5A93E0Q28371932-D351B5E5-3457-4B45-BF2C-E55E92F70840Q28468537-C1E794DD-654B-44AE-AE0F-644B982998E0Q30582113-A1DA2E42-479E-4BF1-B682-1C7FDFEAE057Q33238284-56A60DD7-787F-416F-B4C3-01A84DE8EA20Q33842939-352DBF66-252C-4211-8E35-540C570208C1Q33906599-C3A90ABE-1162-4FE8-919A-97673FFCC30DQ34076610-42392BDE-CAF0-4FE8-AE84-9E6BAB14930CQ34097800-EA0A0229-350A-4CE7-B325-1386AA706D2FQ34102844-57407AA0-882E-4607-8DB6-047B54518957Q34111244-E03702EC-A752-4FE4-8124-6095328A558FQ34385103-0A9780C8-482F-4DB3-B04A-097FF543CA23Q34462674-FB06848E-2DE4-49DE-8A8F-D6A7BDAF2457Q34553382-B0EF537D-1C34-46DD-A850-19250E60770FQ34639613-E16B9220-7505-4229-AEAA-DDBAB1E32158Q35669027-EF929B0C-6E08-4A56-B3EC-2B7F0172F109Q35782217-36E8E020-9A4F-4A0B-A7C8-D550441BE1C2Q35798724-6F287789-BF2A-4D7E-8D2A-321FAD457EFBQ36050817-D8797639-DE8B-4FD8-9A5B-9530A15082D9Q36097981-0F8C54EA-D2D5-4C9D-AD78-59447E01CA75Q36832111-0B9C9D67-23A3-4AD5-84E5-770E66C4A724Q36851188-B2E861F6-5607-4EA2-AB4C-37DD6CD11714Q37142420-304FB283-9789-4BDA-A7B0-111899652FC4Q37944795-FEF85F21-C753-498D-8A15-4791DDE365DAQ38108291-0D7DD351-D0ED-4FD2-BB37-929C4589F091Q39412554-BE4D3BBD-D657-493D-95A2-4C00DA648B10Q39679820-E6A0E6A6-9FDF-46E1-BE1C-678320FB4CA9Q40149770-0C12B396-3734-4612-901A-2D4E4F75E9ACQ40710630-7608509B-4FC4-4F45-BCE4-82287D6A75B9Q40912925-50D62E7D-93D2-4667-92F6-9CA562CCE07BQ41204522-A65DB419-E690-4A58-A72B-6406599F9496Q41565391-15D47F87-C9A8-4FCB-9693-A0FC62559DC9Q41565410-21439C44-8EE0-4157-AAB9-ABCBD4CB436AQ41591386-314F2FF2-87C5-4F4C-AF4B-440E0A4BB29AQ41938190-9F6FEA3C-0B51-4BBF-B5A9-E4E82D9289C3Q42558745-474174D7-8EC0-4130-A2DD-D0C64D694F26Q42750908-F8F4D3FD-3550-4F3A-B2CD-E552E198A86DQ42917054-5013D04F-F74E-4ADA-86FB-61E3DE618AADQ43154272-91847DA0-7E37-452E-A4DD-9FE1933C1EC7
P2860
Drug-induced gingival overgrowth: old problem, new problem.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug-induced gingival overgrowth: old problem, new problem.
@en
Drug-induced gingival overgrowth: old problem, new problem.
@nl
type
label
Drug-induced gingival overgrowth: old problem, new problem.
@en
Drug-induced gingival overgrowth: old problem, new problem.
@nl
prefLabel
Drug-induced gingival overgrowth: old problem, new problem.
@en
Drug-induced gingival overgrowth: old problem, new problem.
@nl
P1476
Drug-induced gingival overgrowth: old problem, new problem.
@en
P2093
P304
P356
10.1177/10454411910020010201
P407
P577
1991-01-01T00:00:00Z